The peroxisome proliferator-activated receptor γ (PPARγ) is generally regarded as a molecular target for the thiazolidinedione class of anti-diabetic drugs [5,6], as it plays a key role in the generation and development of diabetes mellitus [7,8,9]. Here, PPARG is linked to diabetes mellitus.